INTRODUCTION
Endometrial adenocarcinoma represents 90% of tumors in the uterine body and is the fourth commonest neoplasm in Western women and the fifth among Brazilians. Among gynecological cancers it ranks second as the cause of death. [1] [2] [3] The incidence of this type of cancer has been increasing in the Brazilian population. 4 The classical prognostic factors are histological type and grading, depth of myometrial invasion and extent in the cervix. [5] [6] [7] It has been suggested that the expression of p53 protein, as well as estrogen and progesterone receptors, may have prognostic significance. 8, 9 p53 protein is expressed more in aggressive tumors, which suggests that mutation of the gene renders the neoplastic cells resistant to apoptosis. 10 On the other hand, estrogen and progesterone receptors are usually associated with well-differentiated endometrial tumors. 8, [10] [11] [12] Our aims were: 1) to compare histological type and grading of endometrial carcinoma in curettage and hysterectomy samples; 2) to assess the expression of p53, estrogen and progesterone receptors in curettage specimens; and 3) to correlate these data with morphology and staging of the disease in the hysterectomy specimens.
METHODS
A review was made of 51 consecutive cases of endometrioid carcinoma from January 1994 to December 1998. For all patients, diagnostic curettage and hysterectomy specimens, intraoperative frozen sections and paraffin sections, were available.
Representative 4 µm sections from formalin-fixed, paraffin-embedded curettage specimens were histologically classified, according to the World Health Organization guidelines, 13 as endometrioid or non-endometrioid types. Based on the International Federation of Gynecology and Obstetrics (FIGO) criteria, 14 the histological grades for endometrial carcinoma are: well-differentiated or grade I; moderately differentiated or grade II; and poorly differentiated or grade III. In accordance with the disease stage, the histological parameters evaluated were depth of myometrial invasion, extent in the cervix and lymph node metastasis.
Further sections from the same tissue were submitted to immunohistochemical reactions for p53, estrogen and progesterone receptors, via the avidin-biotin-peroxidase method, using antigen recovery with microwave oven (15 minutes, citrate buffer 0.01N, pH 6.0). The primary antibodies for detecting p53 and progesterone receptors were, respectively: Dako D07 (code M7001), dilution 1:100; and Dako 1AE (code M3529-1), dilution 1:100. For estrogen, non-commercial antibody from a private source (University of Toulouse), was used at dilution 1:2000. Positive and negative controls for all procedures were obtained from duct breast carcinoma for estrogen and progesterone receptors and colon adenocarcinoma for p53. Immunohistochemical reactions occur in the nucleus, which acquires a brownish color; when more than 10% of tumor cell nuclei became stained, the reaction was considered positive.
Original Article
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RESULTS
The sample consisted of 51 women with endometrioid carcinoma, with ages ranging from 43 to 83 years (mean of 64 years); 44 cases (86%) were of endometrioid and 7 (14%) nonendometrioid carcinoma (Figures 1 and 2) . The 44 endometrioid carcinoma cases were graded as follows: grade I = 26/44 (59.1%), grade II = 13/44 (29.5%) and grade III = 5/44 (11.4%).
The curettage diagnoses were compared to those from the hysterectomy. Diagnostic agreement regarding histological type and grade was observed in 80%.
According to the stage of the disease the majority of the patients were diagnosed in stage I. However, non-endometrioid carcinoma was mainly diagnosed in more advanced stages (71%, Table 1 ).
Markers and histological types: p53 expression was found in 16% of the endometrioid and in 71% of the non-endometrial carcinomas ( Figure 3) ; the estrogen and progesterone receptors were more frequent in the endometrioid type (Table 2) .
Markers and histological grade: In the 44 cases of endometrioid carcinoma, those with grade I expressed estrogen (15 out of 26 cases = 63%) and progesterone receptors (21 out of 26 cases = 68%) more frequently than those with grades II and III. p53 was expressed in only 16% of endometrioid carcinomas, the majority of which were grade II or III (Table 3) .
Markers and final disease stage: The expression of the markers in curettage material did not bear a significant relationship to the final disease stage as evaluated in the hysterectomy specimens (Table 4) . We observed a slight increase in p53 positivity in the advanced stages.
DISCUSSION
Our results agree with the literature with regard to the higher frequencies of the endometrioid type and histological grade I (well-differentiated) carcinomas. [5] [6] [7] [15] [16] [17] Non-endometrioid carcinoma predominated in elderly women, as expected, although the frequency of 14% was higher than found in other studies. 5, 6 This difference may be attributable to the relatively small size of the population studied and the fact that our service is a reference center in which complex cases are concentrated.
The 80% diagnostic agreement between the two procedures can be explained by the small size of the fragments obtained at curettage. Most patients were in stage I at diagnosis: this correlates with the predominance of the endometrioid type, which has slower progression. On the other hand, most non-endometrioid carcinomas were in stages II or III, although this was not statistically significant due to the small size of the sample. All these observations are in accordance with the literature. 5, 6, 15, 18 p53 was significantly more expressed in non-endometrioid (71%) than in endometrioid carcinoma (16%), and was mostly in histological grades II and III. This indicates possible mutation of p53 as an early event, which is typical of the carcinogenic pathway for non-endometrioid carcinomas. [19] [20] [21] Conversely, estrogen and progesterone receptors are more frequently positive in endometrioid carcinoma, particularly if well-differentiated, as reported by others.
9,18,21-23 However, in our results, only progesterone receptor expression was statistically significant, which could possibly be explained by the antibodies coming from different sources or having different sensitivity and specificity, as reported by others. 23 We were able to confirm that p53 expression is inversely related to that of estrogen and progesterone receptors, thus indicating a dual theory of carcinogenesis in the endometrium. 11, [23] [24] [25] [26] Expression of the markers studied was not significantly associated with the disease stage. It has been reported that p53 expression correlates with more advanced stages. 23, 25, 27, 28 Although we found slightly greater p53 expression in stages II and III, this was not statistically significant.
CONCLUSION
We conclude that the expression of p53, estrogen and progesterone receptors in curettage material was no more valuable for predicting the disease stage than the classical morphological criteria of histological type and grading. 
